Jane Street Group, LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History
Jane Street Group, LLC
- $384 Billion
- Q1 2025
A detailed history of Jane Street Group, LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 44,916 shares of RVPH stock, worth $18,415. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,916
Previous 70,100
35.93%
Holding current value
$18,415
Previous $66,000
36.36%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RVPH
# of Institutions
58Shares Held
8.04MCall Options Held
938KPut Options Held
40.8K-
Vanguard Group Inc Valley Forge, PA1.8MShares$739,6770.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$629,0690.0% of portfolio
-
Diadema Partners LP Morristown, NJ651KShares$266,7960.16% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K3641KShares$262,8810.18% of portfolio
-
Tang Capital Management LLC San Diego, CA510KShares$209,2340.03% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $8.38M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...